Menalled Liliana, El-Khodor Bassem F, Hornberger Monica, Park Larry, Howland David, Brunner Dani
Senior Principal Scientist at PsychoGenics, Inc.; Senior Research Scientist, Pfizer Inc.; Data Manager at Psychogenics, Inc; Director, PreClinical Research, CHDI Foundation, Inc; Director of In Vivo Biology, CHDI Foundation Inc and Senior VP Behavioral R&D at PsychoGenics, Inc.
PLoS Curr. 2012 Feb 13;4:RRN1303. doi: 10.1371/currents.RRN1303.
Homozygosis for the rd1 mutation in the Pbe6b gene results in the loss of the rod beta-subunit of the cyclic GMP phosphodiesterase and, eventually, of all rod and cone photoreceptors. The R6/2 mouse line is a widely used model of Huntington's disease (HD). The original line was made available on a mixed background obtained by crossing, via ovarian transplant, female R6/2 (on a B6CBA mixed background) with male B6CBAF1/J mice. As the CBA/J strain used in the US is homozygous for the rd1 mutation and the breeding scheme does not ensure heterozygosis for the mutation, a significant percentage of the offspring on this mixed background is expected to be homozygous for the rd1 mutation. We investigate here the effect of rd1 homozygosis on motor function and examined the effects of the mutation on the R6/2 phenotype. Homozygosis for the rd1 mutation resulted in increased activity in the open field test and reduced rotarod test performance. In addition, rd1 mutation absence or heterozygosis reduced the differences between the R6/2 and the WT mice. Our recommendation for the neurodegeneration field, and for all mouse studies in general, is to carefully control homozygosis for retinal degeneration mutation, even when using tests of motor function.
Pbe6b基因rd1突变的纯合性会导致环鸟苷酸磷酸二酯酶的视杆β亚基丧失,并最终导致所有视杆和视锥光感受器丧失。R6/2小鼠品系是亨廷顿病(HD)广泛使用的模型。最初的品系是通过卵巢移植将雌性R6/2(在B6CBA混合背景上)与雄性B6CBAF1/J小鼠杂交,在混合背景上培育出来的。由于美国使用的CBA/J品系对rd1突变是纯合的,且育种方案不能确保该突变的杂合性,预计在这种混合背景下,相当比例的后代会是rd1突变的纯合子。我们在此研究rd1纯合性对运动功能的影响,并检测该突变对R6/2表型的影响。rd1突变的纯合性导致旷场试验中的活动增加,转棒试验表现降低。此外,不存在rd1突变或为杂合子时,R6/2小鼠和野生型小鼠之间的差异会减小。我们对神经退行性疾病领域以及所有一般小鼠研究的建议是,即使在进行运动功能测试时,也要仔细控制视网膜变性突变的纯合性。